Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)

Market Cap	11.77B +310.8%
Revenue (ttm)	21.34M -21.0%
Net Income	-676.25M
EPS	-10.59
Shares Out	115.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,055,300
Average Volume	8,145,735
Open	99.00
Previous Close	101.00
Day's Range	99.00 - 105.00
52-Week Range	38.00 - 350.00
Beta	1.53
RSI	41.49
Earnings Date	Feb 13, 2026

About TYO:4596

Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices worldwide. The company offers eyeMO remote retinal monitoring device patient-based ophthalmology suite, that includes home-based miniature and NASA high-res version optical coherence tomography devices. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. Kubota Pharmaceutical Holdings Co., Lt...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 19
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4596

Financial Performance

In 2025, TYO:4596's revenue was 21.34 million, a decrease of -20.98% compared to the previous year's 27.00 million. Losses were -676.25 million, -49.23% less than in 2024.